A second ACE of hearts

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 9, 2003, Pages 1009-1010

  London, Barry ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CONNEXIN 43; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; EDITORIAL; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; GENETIC PREDISPOSITION; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; KNOCKOUT MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0041328961     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00201-3     Document Type: Editorial

References (16)

1. Dzau V.J. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Int M. 153:1993;937-942.
2. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J. Jr, Cuddy T.E., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. New Engl J M. 327:1992;669-677.
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J M. 325:1991;293-302.
4. Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). JAMA. 283:2000;1295-1302.
5. McNamara D.M., Holubkov R., Janosko K., Palmer A., Wang J.J., MacGowan G.A., et al. Pharmacogenetic interactions between beta blocker therapy and the angiotensin converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation. 103:2000;1644-1648.
6. Zipes D. Genesis of cardiac arrhythmias: electrophysiological considerations; management of cardiac arrhythmias: pharmacological, electrical, and surgical techniques; and specific arrhythmias: diagnosis and treatment. Braumwald E. Heart disease: a textbook of cardiovascular medicine. 1997;548-704 W.B. Saunders Company, Philadelphia.
7. Sadoshima J., Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res. 73:1993;413-423.
8. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 275:2000;33238-33243.
9. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 87:2000;E1-E9.
10. Crackower M.A., Sarao R., Oudit G.Y., Yagil C., Kozieradzki I., Scanga S.E., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417:2002;822-828.
11. Donoghue M., Wakimoto H., Maguire C.T., Acton S., Hales P., Stagliano N., et al. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with down-regulated connexins. J Mol Cell Cardiol. 35:2003;1041-1051. in this issue.
12. London B. Cardiac arrhythmias: from (transgenic) mice to men. J Cardiovasc Electrophysiol. 12:2001;1089-1091.
13. Gutstein De, Morley G.E., Tamaddon H., Vaidya D., Schneider M.D., Chen J., et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 88:2001;333-339.
14. Simon A.M., Goodenough D.A., Paul D.L. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol. 8:1998;295-298.
15. Kasahara H., Wakimoto H., Liu M., Maguire C.T., Converso K.L., Shioi T., et al. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homoprotein. J Clin Invest. 108:2001;189-201.
16. Kuo H.C., Cheng C.F., Clark R.B., Lin J.J., Lin J.L., Hoshijima M., et al. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell. 107:2001;801-813.